Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs

E-ISSN： 1476-5829|13|4|398-408

ISSN： 1476-5810

Source： VETERINARY AND COMPARATIVE ONCOLOGY, Vol.13, Iss.4, 2015-12, pp. : 398-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral melphalan for the treatment of relapsed canine lymphoma

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : E123-E129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 3, 2015-09 ,pp. : 184-193

John Wiley & Sons Inc

Access to resources Recommend Favorite

A dexamethasone, melphalan, actinomycin‐D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : E144-E151

John Wiley & Sons Inc

Access to resources Recommend Favorite

LOPP chemotherapy as a first‐line treatment for dogs with T‐cell lymphoma

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : 108-113

John Wiley & Sons Inc

Access to resources Recommend Favorite

Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 4, 2015-12 ,pp. : 363-372

John Wiley & Sons Inc

Access to resources Recommend Favorite